Dr Lal Path Labs, which operates diagnostic centres, today said it will invest Rs 150 crore this year on acquisitions in India and abroad.
"We are looking to invest Rs 150 crore in 2011 for acquisitions in southern and western parts of the country as well as abroad," Dr Lal Path Labs Chief Executive Officer Dr Om Manchanda told PTI on the sidelines of a health submit here.
He said the company is also looking to acquire in Middle East, Bangladesh, Sri Lanka and other South Asian nations.
The company, which has 65 laboratories at present in India, said it is looking to add another 35 this year.
"We will try to have about 100 labs by the end of this year," Manchanda said.
